Million Pfizer Covid-19 vaccines expected in March 2021 Western Australia

Million Pfizer Covid-19 vaccines expected in March 2021 Western Australia

Health Minister Roger Cook reveals, that Western Australia will get 1 million Pfizer Covid-19 Vaccines expected to arrive in Western Australia in March 2021.

A vaccine made by US pharmaceutical giant Pfizer and its German partner BioNTech. A final analysis of the Phase 3 trial of the vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, Pfizer said last month.
The announcement means Western Australia get the vaccine in March.
Elderly people in care homes, those who care for them, health workers and other vulnerable people will be top of the priority list to get vaccinated first.

Million Pfizer Covid-19 vaccines expected to be delivered in March 2021 to Western Australia

As more vaccine doses become available in March, it will be provided at large vaccination centres, and local pharmacists should be able to offer it from most likely from March-May 2021.

The rollout will then filter down to the general public by age, with older groups coming first. Individuals with underlying health conditions that make them vulnerable to the virus will be able to receive the shot after the over-65 group is vaccinated.

Nobody wants lockdowns and to see the damage they do. But if you want that dream to come true as quickly as it can come true, then you have to take the vaccine when it’s offered to you. Low uptake will almost certainly make restrictions last longer.

Covid-19 Pfizer Vaccines information and approvals

– U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediately
– First authorization for a COVID-19 vaccine represents a breakthrough scientific achievement to help combat this devastating pandemic
– The companies previously signed an agreement to supply a total of 40 million doses to the U.K. with delivery in 2020 and 2021
– U.S. FDA and EU EMA decisions on authorization are expected in December

To assure product quality, the companies have developed specially designed, temperature-controlled shippers for the BNT162b2 vaccine candidate, which can maintain recommended storage conditions (-70°C ±10°C) for extended periods of time without any additional equipment but dry ice. The shipper can maintain temperature for 10 days unopened which allows for transportation to markets globally. Once open, a vaccination centre may use the specially designed shippers as a temporary storage solution to maintain the recommended storage conditions (-70°C ±10°C) up to 30 days with re-icing every five days in accordance with the handling instructions. Each shipper contains a GPS-enabled thermal sensor to track the location and temperature of each vaccine shipment 24 hours a day, seven days a week. Once thawed, the vaccine vial can be stored for up to five days at refrigerated (2-8°C) conditions. source: Pfizer

BioNTech and Pfizer submitted their vaccine candidate to the FDA in mid-November, and the regulator’s Vaccines and Related Biological Products Advisory Committee is due to meet on December 10 to consider authorization. They have also submitted their candidate to the European Medicines Agency (EMA), which is set to deliver a verdict later in December.
Another vaccine, from US biotech firm Moderna, is awaiting approval in various countries, including the US and UK. The company expects to have 20 million doses available in the US by the end of the year and 500 million to 1 billion in 2021

More about the vaccines in Article >> Read More

Scott Morrisson Prime minister of Australia said,

The Australian government and Health Minister will most likely give approval to Covid-19 vaccines in January 2021. Do not expect any approval before January 2021.

0 Comments Be First to Comment

Leave a Reply

Your email address will not be published.

You may have missed
Denmark suspends use of AstraZeneca COVID-19 vaccine